Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Closure of Buy Back with effect from Jun 02, 2026
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals Limited has informed the stock exchange that its share buyback programme will close with effect from June 2, 2026. The company has not disclosed any further details about the buyback size, price, or the number of shares tendered in this particular intimation. This filing is essentially a regulatory update notifying the end of the buyback window. Shareholders who intended to tender shares will need to do so before the closure date.
No direct share price impact expected from this announcement alone, as it only marks the end of the buyback window. Existing shareholders who haven't tendered yet have limited time to participate before the programme closes.